YOU ARE HERE > MONEYCONTROL > MARKETS > PHARMACEUTICALS > News - Dr Reddys Laboratories

Dr Reddys Laboratories

BSE: 500124|NSE: DRREDDY|ISIN: INE089A01023|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Feb 25, 16:00
4479.25
37.75 (0.85%)
VOLUME 118,578
LIVE
NSE
Feb 25, 16:02
4480.15
44.6 (1.01%)
VOLUME 1,706,375
News on Dr Reddys Laboratories
Select Year: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2000-2005
Dr Reddy's seeks approval from Health Canada for Favipiravir

12.49 pm | 22 Dec 2020 |  Source: PTI

The application was filed under Health Canada's "Interim Order Respecting the Importation, Sale and Advertising of Drugs for Use in Relation to CO...

This is how DBT is helping companies accelerate development of COVID-19 vaccine

7.08 pm | 07 Dec 2020 |  Source: Moneycontrol.com

The Department of Biotechnology has prepared 11 clinical trial sites across the country that would help developers test the COVID-19 vaccine candidate...

Dr Reddy's to acquire select brands from Glenmark in Russia, Ukraine

7.48 am | 29 Nov 2020 |  Source: PTI

The acquired brands represent two types of products -- mometasone mono product and combination of mometasone with azelastine, which are indicated for ...

Russia's Sputnik V COVID-19 vaccine to be produced in India; RDIF and Hetero agree to make over 100 million doses

1.00 pm | 27 Nov 2020 |  Source: Moneycontrol.com

COVID-19 Vaccine Tracker: This is the second such partnership by an Indian company with RDIF. Earlier, Dr Reddy's partnered with RDIF to conduct c...

COVID vaccine | Sputnik V shows 91.4% efficacy in second interim analysis on day 28 after first dose

5.04 pm | 24 Nov 2020 |  Source: Moneycontrol.com

The cost of one dose of the Sputnik V vaccine for international markets will be less than $10. Sputnik V is a two dose vaccine....

Why Lupin’s Solosec is a cautionary tale for the much-hyped speciality drug business

4.58 pm | 10 Nov 2020 |  Source: Moneycontrol.com

The company’s speciality business has contracted 50 percent, as Covid continues to take a toll and limits its ability to promote Solosec to prescrib...

Dr Reddy's plans to complete phase 3 trial of Sputnik V COVID vaccine by March end

9.19 pm | 28 Oct 2020 |  Source: Moneycontrol.com

CEO Erez Israeli said the company would begin phase II trials in the next few days...

Cyber attack that led to pause in worldwide operations was ransomware, investigation continues: Dr Reddy's

3.44 pm | 28 Oct 2020 |  Source: Moneycontrol.com

In a ransomware attack, the hackers breach the systems, install malware that encrypts a victim's files, then demand a ransom from the victim to re...

Dr Reddy's launches generic product in US to treat gastroesophageal reflux disease

4.18 pm | 20 Oct 2020 |  Source: PTI

Famotidine tablets are used to prevent and relieve heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certai...

Russia's COVID-19 vaccine Sputnik V makes headway in India

12.23 pm | 18 Oct 2020 |  Source: Moneycontrol.com

Dr Reddy's gets the nod to conduct human trials for the vaccine while Mankind Pharma signs an agreement with RIDF that will make 300 million doses...

Dr Reddy's launches generic version of Sapropterin Dihydrochloride tablets in US market

1.25 pm | 03 Oct 2020 |  Source: PTI

This product demonstrates that the company is actively expanding the breadth of its portfolio with a treatment for a rare disease, he added....

Dr Reddy's seeks DCGI nod to conduct phase-3 clinical trial of Russian COVID-19 vaccine Sputnik V

10.47 pm | 02 Oct 2020 |  Source: PTI

The Indian pharma giant has collaborated with The Russian Direct Investment Fund (RDIF) to conduct clinical trials of Sputnik V as well as its distrib...

Dr Reddy's launches generic drug in US market

2.00 pm | 25 Sep 2020 |  Source: PTI

The Hyderabad-based company's Dexmedetomidine Hydrochloride in 0.9 per cent Sodium Chloride injection is the generic version of Hospira Inc's ...

India trials for Russia's 'Sputnik-V' vaccine may begin in next few weeks: Dr Reddy's

3.41 pm | 22 Sep 2020 |  Source: Reuters

Indian trials of the Sputnik-V vaccine candidate, being developed by Russia's sovereign wealth fund, will enroll 1,000-2,000 participants and be c...

Dr Reddy's launches OTC eye allergy drop in US

12.10 pm | 17 Sep 2020 |  Source: PTI

The newly-launched product is the storebrand equivalent of Novartis AG''s Pataday, the drug major said in a regulatory filing....

Dr Reddy's launches generic arthritis drug in US market

12.01 pm | 09 Sep 2020 |  Source: PTI

"The launch of product is an important addition to our pain/analgesics portfolio of over-the-counter (OTC) products, and represents our continued comm...

USFDA ‘closes' warning letter for three sites of Dr Reddy's Laboratories

12.50 pm | 28 Aug 2020 |  Source: PTI

In November 2015, the company said it had received a warning letter from the US Food and Drug Administration (USFDA) for three of its sites -- active ...

Dr Reddy's Laboratories forays into hospital nutrition segment with Celevida Maxx in India

11.31 am | 25 Aug 2020 |  Source: PTI

It is a unique addition to Dr Reddy's nutrition portfolio and is designed to help manage the nutritional needs of Cancer, Critical Care and Chroni...

Coronavirus treatment | Dr Reddy's launches Avigan (Favipiravir) tablets in India

1.10 pm | 19 Aug 2020 |  Source: PTI

Dr Reddy's said Avigan has been approved by the Drugs Controller General of India (DCGI) for the treatment of patients with mild to moderate COVID...

Dr Reddy's launches generic Ciprodex in US market

10.05 am | 11 Aug 2020 |  Source: PTI

Ciprodexis used in adults and children 6 months of age or older to treat certain types of infections caused by certain germs called bacteria....

1 2 3 4
Quick Links for Dr Reddys Laboratories
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.